Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-05

Clinical Trial Update: Cholesterol in ASD: Characterization and Treatment [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial investigated cholesterol-related aspects and potential treatment approaches in autism spectrum disorders, including a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Autism, Asperger Disorder | Phase 1, Phase 2 | Status: COMPLETED